The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear
Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
SIFI is currently evaluating various options for the commercialization of Akantior (polihexanide) globally, including potential out-license agreements outside its core markets
Resolv ER may remedy leading causes of blindness in adults
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
